Female infertility stems from a wide range of causes, but most cases trace back to problems in one of a few key areas: ovulation, the fallopian tubes, or the uterus. Ovulatory disorders alone account for a large share of diagnoses, with polycystic ovary syndrome (PCOS) being the single most common culprit. Yet the reality is more layered than any single category suggests, because age, genetics, immune function, environmental exposures, and even the reproductive tract’s microbial community all play roles that researchers are still working to untangle.
Ovulatory Disorders
For pregnancy to happen, a mature egg has to be released from the ovary each cycle. When that release fails repeatedly, the condition is called anovulation, and it is one of the leading reasons women have trouble conceiving. PCOS is by far the most common cause. In women with PCOS, follicles start to grow in the ovary but stall before any one of them matures enough to ovulate. That arrested development is driven by a cascade of hormonal imbalances: overproduction of luteinizing hormone (LH) and insulin, along with high androgen levels inside the follicles, which together suppress the follicle-stimulating hormone (FSH) needed to push a single follicle to full maturity.1Human Reproduction Update. Follicle dynamics and anovulation in polycystic ovary syndrome The hypothalamus also contributes by firing off GnRH pulses too rapidly, which skews the LH-to-FSH ratio even further.2Current Opinion in Endocrine and Metabolic Research. What causes anovulation in polycystic ovary syndrome? There is also evidence that something goes wrong much earlier in the process, at stages of follicle development that do not even depend on hormones yet, suggesting an intrinsic defect in how the egg and its surrounding cells communicate.3Human Reproduction Update. Follicle dynamics and anovulation in polycystic ovary syndrome
PCOS is not the only reason ovulation shuts down. Functional hypothalamic amenorrhea (FHA) is a distinct condition in which the brain’s signaling to the ovaries goes quiet. Unlike PCOS, where hormone levels run too high in certain respects, FHA involves too little GnRH. The triggers are stress, undereating, and excessive exercise, often in combination. When your body senses that energy availability is too low, it essentially decides that reproduction is a luxury it cannot afford and dials down the hormonal chain from the hypothalamus on down.4PubMed Central. Functional Hypothalamic Amenorrhea: Recognition and Management of a Challenging Diagnosis Genetic susceptibility may influence how sensitive a given person is to these triggers.5PubMed. Kisspeptin in functional hypothalamic amenorrhea: Pathophysiology and therapeutic potential FHA is sometimes misdiagnosed as PCOS or vice versa, and the distinction matters because the treatments are very different: PCOS management often involves medications that address insulin resistance or stimulate ovulation, while FHA usually requires nutritional rehabilitation and stress reduction.
Egg Quality and the Age Factor
Age is arguably the most powerful single predictor of a woman’s fertility, and the reason is primarily the egg, not the uterus. Women are born with all the eggs they will ever have, and those eggs age alongside the rest of the body. As oocytes sit in the ovary for decades, their cellular machinery deteriorates. Mitochondria, which supply the energy an egg needs to divide correctly after fertilization, become less efficient. The spindle apparatus that pulls chromosomes apart during cell division becomes error-prone. The combined result is a sharp rise in chromosomal abnormalities in eggs as a woman moves through her thirties and into her forties.6PubMed Central. Oocyte aging underlies female reproductive aging: biological mechanisms and therapeutic strategies Oxidative stress and mitochondrial damage are considered major drivers of this decline.7PubMed Central. Oocyte quality and aging
Alongside quality, quantity also drops. The pool of remaining follicles shrinks with every cycle, and anti-Müllerian hormone (AMH) levels in the blood reflect this. AMH is produced by small growing follicles, so a declining AMH signals a shrinking reserve. It is currently considered the best available blood marker for what clinicians call functional ovarian reserve.8PubMed Central. Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function AMH is useful for guiding medication dosing in fertility treatments and flagging who might respond poorly or too aggressively to ovarian stimulation, but it has limited ability to predict whether a given cycle will result in pregnancy.9Human Reproduction Update. Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications That distinction trips people up: a low AMH means fewer eggs are available, but it does not necessarily mean the eggs you do have are poor quality. Conversely, a reassuringly “normal” AMH in your late thirties does not guarantee the eggs are chromosomally sound.
Tubal Damage and Pelvic Inflammatory Disease
The fallopian tubes are not passive corridors. They catch the egg after ovulation, provide the site where sperm and egg meet, and use muscular contractions and tiny hair-like cilia to ferry the early embryo toward the uterus. Damage to these tubes is one of the oldest recognized causes of infertility, and pelvic inflammatory disease (PID) remains the chief culprit. PID is usually the result of ascending bacterial infection, most often from sexually transmitted organisms like chlamydia and gonorrhea, though other bacteria can be involved.
The damage is cumulative. A landmark follow-up study of over 400 women treated for confirmed PID found that tubal blockage occurred in about 13% of women after a single episode, jumped to roughly 35% after two infections, and reached 75% after three or more.10American Journal of Obstetrics and Gynecology. Effect of acute pelvic inflammatory disease on fertility Even when tubes are not fully blocked, PID can leave adhesions and scarring that distort the normal anatomy, raising the risk of ectopic pregnancy on top of reducing fertility.11PubMed. Pelvic Inflammatory Disease: Multimodality Imaging Approach with Clinical-Pathologic Correlation What makes PID particularly insidious is that chlamydia infections in particular can be nearly silent, producing no noticeable symptoms while quietly causing tubal inflammation. A significant number of women discover tubal damage only when they start trying to conceive.
Endometriosis
Endometriosis occurs when tissue similar to the uterine lining grows outside the uterus, commonly on the ovaries, fallopian tubes, and pelvic lining. It affects an estimated one in ten women of reproductive age, and among women struggling with infertility, the proportion is considerably higher. The exact pathways by which endometriosis impairs fertility are still debated, but the list of suspects is long. The ectopic tissue triggers chronic inflammation in the pelvis, attracting immune cells that release compounds creating a hostile environment for eggs, sperm, and embryos.12PubMed Central. Ethiopathogenic mechanisms of endometriosis-related infertility
Evidence points to multiple disruptions happening at once. Follicle development can be abnormal, oxidative stress within the follicular fluid may compromise egg quality, and the peritoneal fluid surrounding the reproductive organs can interfere with sperm function.13PubMed. Pathogenic mechanisms in endometriosis-associated infertility Endometriosis also appears to reduce the receptivity of the uterine lining itself, making implantation harder even when a healthy embryo reaches the right place.14PubMed Central. Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility Advanced endometriosis can also form ovarian cysts called endometriomas, which physically reduce the available pool of healthy ovarian tissue. In short, endometriosis can undermine nearly every step of conception, which helps explain why it remains so difficult to treat with any single intervention.
Uterine Structural Problems
Even when ovulation and tubal transport work perfectly, structural issues inside the uterus can prevent an embryo from implanting or a pregnancy from continuing. Fibroids, which are benign muscular growths in the uterine wall, are extremely common. Not all fibroids cause fertility problems; the ones that matter most are those that distort the uterine cavity. Cavity-distorting fibroids have been linked to lower implantation and pregnancy rates and higher miscarriage rates, likely because they physically compress the endometrium or block the openings of the fallopian tubes.15Human Reproduction. Infertility in patients with uterine fibroids: a debate about the hypothetical mechanisms Fibroids that sit entirely within the muscular wall or on the outer surface of the uterus are less clearly tied to infertility, which is why management decisions depend heavily on the fibroid’s location and size.
Endometrial polyps, small overgrowths of the uterine lining, may also play a role, though the evidence is less definitive and there is no consensus on how aggressively they should be removed in women trying to conceive.16PubMed Central. Management of endometrial polyps in infertile women: A mini-review Intrauterine adhesions, sometimes called Asherman’s syndrome, present a more clear-cut problem. These bands of scar tissue can form after uterine surgery, severe infections, or tuberculosis, and they physically obstruct the cavity. When the scarring extends deep enough to damage the basal layer of the endometrium, even surgical removal of the adhesions may not restore the lining’s ability to regenerate properly.17PubMed Central. Reproductive Outcome of Patients with Asherman’s Syndrome: A SAIMS Experience Congenital uterine anomalies like a septate uterus can have similar effects, though many go undetected until a woman experiences recurrent miscarriage.
Premature Ovarian Insufficiency
Premature ovarian insufficiency (POI), sometimes called premature menopause, describes the loss of normal ovarian function before age 40. The ovaries stop releasing eggs and produce far less estrogen. For many women with POI, the cause is never identified. Among the cases that can be traced, autoimmune disease stands out. Estimates suggest that anywhere from 4 to 30% of POI cases have an autoimmune origin, where the body’s immune system attacks the ovaries.18PubMed Central. Autoimmune Diseases in Patients with Premature Ovarian Insufficiency-Our Current State of Knowledge
A recent large study found that about a quarter of women with POI had at least one diagnosed autoimmune condition, with dramatically elevated risk for autoimmune thyroid disease, adrenal insufficiency, type 1 diabetes, celiac disease, rheumatoid arthritis, and several other conditions compared to the general population.19The Journal of Clinical Endocrinology & Metabolism. Autoimmune Disease is Increased in Women With Primary Ovarian Insufficiency Chromosomal abnormalities are another recognized cause. Turner syndrome (missing one X chromosome) and certain X-chromosome rearrangements account for close to 10% of POI cases by accelerating the loss of eggs during fetal development, sometimes leaving virtually no functioning ovarian tissue at birth.20Biology of Reproduction. Genetics of human female infertility Genetic mutations affecting specific genes involved in oocyte maintenance, DNA repair, and hormone signaling have also been identified, though individually each one is rare.
Thyroid Disorders and Other Endocrine Disruptions
The thyroid gland operates far from the reproductive organs, but its hormones influence nearly every cell in the body, including the ovaries. Both an underactive and overactive thyroid can disrupt menstrual regularity and cause anovulation. In hypothyroidism, the mechanism involves a chain reaction: the brain ramps up production of thyrotropin-releasing hormone (TRH), which in turn pushes up prolactin secretion from the pituitary. Elevated prolactin suppresses the normal hormonal pulses needed for ovulation.21PubMed Central. Role of hypothyroidism and associated pathways in pregnancy and infertility: Clinical insights The good news is that thyroid-related infertility is among the most treatable causes, since restoring normal thyroid levels with medication usually restores normal cycles. Screening for thyroid problems is now standard in most fertility workups, yet mild thyroid dysfunction still gets missed when symptoms are attributed to stress or other causes.
Antiphospholipid antibody syndrome (APS), an autoimmune condition in which the blood has a tendency to clot abnormally, has also been linked to both infertility and pregnancy loss. The antibodies involved may interfere with the uterine lining’s preparation for implantation and directly damage the placenta’s early development through inflammation and impaired blood flow.22PubMed. Antiphospholipid Antibody Syndrome and Infertility APS is often investigated after recurrent miscarriage, but there is growing interest in whether it also contributes to difficulty conceiving in the first place.
Weight, Smoking, and Other Lifestyle Factors
Obesity affects fertility through multiple overlapping pathways. Excess body fat alters the hormonal environment, lowering gonadotropin levels and disrupting the signaling between the brain and the ovaries. Elevated insulin, glucose, and free fatty acids directly impair egg maturation and the developmental capacity of the resulting embryo.23PubMed Central. The impact of obesity on egg quality Obese women also show higher miscarriage rates and poorer outcomes with IVF.24PubMed Central. Role of Obesity in Female Reproduction None of this means weight loss is a guaranteed fix. Fertility is complex enough that some women at higher weights conceive without difficulty, while others at a healthy weight do not. But when obesity coexists with ovulatory dysfunction, particularly PCOS, addressing weight can meaningfully improve ovulation rates.
Cigarette smoking is another well-established risk factor. A study of women seeking fertility care found that current smokers without PCOS had increased odds of diminished ovarian reserve, with the risk climbing by about 8% for each additional cigarette smoked per day.25PubMed Central. Association between cigarette smoking and ovarian reserve among women seeking fertility care There was also a dose-response pattern with lifetime exposure: more pack-years, higher odds of a depleted egg supply. Smoking appears to accelerate the loss of follicles and introduces toxins that damage DNA inside eggs. Quitting helps, though some of the damage to ovarian reserve may be irreversible.
Environmental Chemicals and Endocrine Disruptors
A growing body of research is raising alarms about synthetic chemicals that mimic or interfere with reproductive hormones. The compounds most frequently implicated in female fertility problems are plasticizers, particularly bisphenol A (BPA) and phthalates such as DEHP.26PubMed Central. The role of endocrine disruptors in female infertility These chemicals are found in food packaging, personal care products, and a wide range of household plastics. Studies indicate BPA can adversely affect oocyte viability, though the exact mechanisms in humans are still being worked out.27PubMed Central. Bisphenol-A and Female Fertility: An Update of Existing Epidemiological Studies
Phthalate metabolites have been detected in the majority of follicular fluid samples tested, meaning these chemicals are getting inside the ovarian environment itself. Lab studies show they can inhibit follicle growth, damage oocytes, and impair maturation.28PubMed Central. Exposure to Multiple Endocrine-Disrupting Chemicals and Associations with Female Infertility Organochlorine and organophosphate pesticides and dioxin-like compounds round out the list of chemicals that have been linked to disrupted female reproduction.29PubMed Central. The role of endocrine disruptors in female infertility The challenge for any individual is that exposure is nearly ubiquitous and often low-level, making it hard to quantify personal risk. Reducing contact with known sources, like heating food in plastic containers or using heavily fragranced products, is a reasonable precaution, though the evidence is not yet strong enough to promise a measurable fertility benefit from any specific behavioral change.
Cancer Treatment and Other Medical Causes
Chemotherapy and pelvic radiation can be devastating to ovarian function. Both treatments are designed to destroy rapidly dividing cells, and eggs and their surrounding follicle cells are vulnerable targets. The degree of damage depends on the type of drug, the cumulative dose, and the patient’s age at the time of treatment, since younger women have a larger ovarian reserve to absorb losses.30PubMed. Ovarian effects of radiation and cytotoxic chemotherapy damage Ionizing radiation directed at the pelvis has particularly potent long-term effects, including ovarian insufficiency and infertility.31PubMed Central. Radiations and female fertility This is why fertility preservation, through egg or embryo freezing before treatment begins, has become a standard part of cancer care planning for women of reproductive age. Ovarian tissue cryopreservation is also an option, especially for prepubertal girls who cannot undergo standard egg retrieval.
Surgical procedures on the ovaries themselves, including repeated removal of endometriomas or cysts, can reduce ovarian reserve by removing healthy tissue along with the disease. Even diagnostic procedures like ovarian drilling for PCOS, while sometimes helpful for triggering ovulation, carry a small risk of damaging the surrounding egg-containing tissue.
The Reproductive Tract Microbiome
The microbial communities living in the vagina, cervix, and uterus have attracted increasing attention from fertility researchers. A healthy reproductive tract is typically dominated by Lactobacillus bacteria, which maintain an acidic environment that discourages pathogens. When Lactobacillus gives way to a more diverse, non-Lactobacillus-dominant community, the shift has been associated with lower rates of implantation, pregnancy, and live birth among women undergoing assisted reproduction.32PubMed Central. Microbiome in Female Reproductive Health: Implications for Fertility and Assisted Reproductive Technologies The findings are intriguing but still early-stage. Researchers have not yet established whether an unfavorable microbiome is a cause of implantation failure, a marker of some other underlying problem, or both. Attempts to “fix” the microbiome with probiotics or antibiotics before fertility treatments are being studied, but no standardized protocol has emerged.
Epigenetic Changes and Oocyte Aging
Beyond the chromosomal errors that accumulate in aging eggs, researchers are also investigating subtler changes in how genes are regulated. During egg development and early embryo growth, a complex process of epigenetic reprogramming takes place, where chemical tags on DNA are erased and rewritten to set the stage for normal development. As oocytes age, this reprogramming process becomes less reliable, and both internal factors like mitochondrial decline and external exposures can introduce errors.33PubMed Central. Oocyte ageing and epigenetics This is a frontier area of research. Understanding how epigenetic errors in eggs contribute to failed implantation, early miscarriage, or developmental problems could eventually open up new treatment avenues, but for now the practical takeaway is mainly that egg quality involves more than just having the right number of chromosomes. The molecular environment inside the egg matters in ways science is only beginning to map.
When No Cause Is Found
After a full fertility workup, roughly one in four couples receives a diagnosis of “unexplained infertility.” This does not mean nothing is wrong; it means current testing cannot identify the specific problem. Standard workups assess ovulation, tubal patency, semen quality, and basic hormonal profiles, but they cannot directly evaluate egg quality at the molecular level, subtle endometrial receptivity problems, or the kinds of immune and inflammatory disruptions described above. As tools improve, more of these cases will likely be reclassified. Some research suggests that a portion of unexplained infertility involves mild endometriosis detectable only by surgery, low-grade tubal dysfunction that does not show up on imaging, or subclinical hormonal patterns that fall within “normal” lab ranges but are suboptimal for conception. For the person living with the diagnosis, unexplained infertility is frustrating precisely because there is no clear target for treatment. Empiric approaches like ovarian stimulation with timed intercourse or IVF often succeed, which itself suggests that the barriers were real but below the threshold of detection.